Gemini Biosciences launches new proteomics and antibody services

We are delighted to introduce our new proteomics and antibody services designed for scientists and researchers developing biopharmaceuticals including bio-similar therapeutic antibodies and comparability studies. The services could also be useful for research scientists who wish to better characterise their reagents prior to use in their research projects.

The new proteomics services we have introduced include: C termini sequencing of proteins,

complete peptide mapping, disulfide bond and protein glycosylation analyses.

As regards new antibody services, we are now offering monoclonal antibody (mAB) impurity

and sequence variant analysis and complete de novo sequencing of monoclonal antibodies,

which makes use of our excellent proteomics services.

Please visit our website for more information about our processes and the applications of these research services.

Featured Posts
Recent Posts
Search By Tags
Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square